Weight gain with tumour necrosis factor-α inhibitors

被引：1
|
作者：
Stamp, L [1 ]
Cross, N
O'Donnell, J
机构：
[1] Univ Otago, Christchurch Sch Med & Hlth Sci, Dept Med, Christchurch, New Zealand
[2] Christchurch Publ Hlth, Dept Rheumatol, Christchurch, New Zealand
[3] Christchurch Publ Hlth, Dept Clin Pharmacol, Christchurch, New Zealand
来源：
INTERNAL MEDICINE JOURNAL | 2005年 / 35卷 / 04期
关键词：
D O I：
10.1111/j.1445-5994.2005.00809.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：267 / 267
页数：1
相关论文
共 50 条
  • [41] Serum tumour necrosis factor-α levels in cancer patients are discontinuous and correlate with weight loss
    Bossola, M
    Muscaritoli, M
    Bellantone, R
    Pacelli, F
    Cascino, A
    Sgadari, A
    Battaglia, F
    Piccioni, E
    Scambia, G
    Doglietto, GB
    Fanelli, FR
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2000, 30 (12) : 1107 - 1112
  • [42] Tumour necrosis factor-α inhibitors/immunosuppressantsExtra-pulmonary tuberculosis: 15 case reports
    Reactions Weekly, 2015, 1546 (1) : 197 - 197
  • [43] DOES TUMOUR NECROSIS FACTOR INHIBITION RESULT IN WEIGHT GAIN IN PATIENTS WITH INFLAMMATORY ARTHRITIS?
    Peter, Wong
    Alison, Bowling
    Cheryl, Tulk
    Di, Freeman
    Hanish, Bagga
    INTERNAL MEDICINE JOURNAL, 2016, 46 : 16 - 17
  • [44] Increased Serum Tumour Necrosis Factor-α in Hidradenitis Suppurativa Patients: Is There a Basis for Treatment with Anti-Tumour Necrosis Factor-α Agents?
    Matusiak, Lukasz
    Bieniek, Andrzej
    Szepietowski, Jacek C.
    ACTA DERMATO-VENEREOLOGICA, 2009, 89 (06) : 601 - 603
  • [45] Pyridostigmine ameliorates preeclamptic features in pregnant rats by inhibiting tumour necrosis factor-α synthetsis and antagonizing tumour necrosis factor-α-related effects
    Zibrila, Abdoulaye Issotina
    Wang, Zheng
    Ali, Md Ahasan
    Osei, James Ampofo
    Sun, Yuyao
    Zafar, Salman
    Liu, Kaili
    Li, Chunfang
    Kang, Yuming
    Liu, Jinjun
    JOURNAL OF HYPERTENSION, 2021, 39 (09) : 1774 - 1789
  • [46] Serum values of tumour necrosis factor-α and of soluble tumour necrosis factor-R55 in melanoma patients
    Ocvirk, J
    Stabuc, B
    Rudolf, Z
    Galvani, V
    Curin-Serbec, V
    MELANOMA RESEARCH, 2000, 10 (03) : 253 - 258
  • [47] The role of tumour necrosis factor-α and tumour necrosis factor receptor signalling in inflammation-associated systemic genotoxicity
    Westbrook, Aya M.
    Wei, Bo
    Hacke, Katrin
    Xia, Menghang
    Braun, Jonathan
    Schiestl, Robert H.
    MUTAGENESIS, 2012, 27 (01) : 77 - 86
  • [48] Risk factors for herpes zoster in rheumatoid arthritis patients: the role of tumour necrosis factor-α inhibitors
    Segan, J.
    Staples, M. P.
    March, L.
    Lassere, M.
    Chakravarty, E. F.
    Buchbinder, R.
    INTERNAL MEDICINE JOURNAL, 2015, 45 (03) : 310 - 318
  • [49] Cost Effectiveness of Tumour Necrosis Factor-α Inhibitors as First-Line Agents in Rheumatoid Arthritis
    James R. Spalding
    Joel Hay
    PharmacoEconomics, 2006, 24 : 1221 - 1232
  • [50] Cost effectiveness of tumour necrosis factor-α inhibitors as first-line agents in rheumatoid arthritis
    Spalding, James R.
    Hay, Joel
    PHARMACOECONOMICS, 2006, 24 (12) : 1221 - 1232
12345